Docs Who Lift

Explore the fascinating effects of tirzepatide on metabolic rates and its surprising links to depression. Discover the real-life implications and psychological risks of GLP-1 medications like semaglutide. Delve into personal stories of overcoming weight loss plateaus through the interplay of mental and physical health. Learn about the costs and accessibility challenges of obesity treatments, and how these affect patients' ability to maintain their health. Join the conversation on modern solutions and the future of diabetes management!

Drs. Karl and Spencer discuss the claim that GLP-1 meds cause more fat cells.Learn about if and how GLP-1 meds increase fat cells and what that means along with other claims about these medicine.Join Dr. Spencer's online clinic that specializes in GLP-1 medicines

Drs. Karl and Spencer talk to Dr. Kenneth Qiu all about direct medical care - the future of medicine.Learn about how bypassing insurance and creating a relationship directly with a doctor can improve your health and save money in the long run.Follow Dr. Qiu on Linked inSee Dr. Spencer's direct care model with Vineyard

In this engaging conversation, Dr. Grant Tinsley, an Associate Professor at Texas Tech University and a body composition expert, discusses the impact of tirzepatide, a leading weight loss medication, on muscle loss. He clarifies the differences between fat-free mass, lean mass, and muscle, emphasizing the importance of precise language in the field. Tinsley also examines how DEXA scans can motivate weight training, strategies to preserve muscle while using tirzepatide, and the need for a holistic approach to muscle growth through nutrition and exercise.

Drs. Karl and Spencer discuss how bad the Hims and Hers ad was.From an outside perspective, the ad may have seemed good.But when you dig deeper, it was actually really bad.Listen to learn.Join Dr. Spencer's new online clinic - Vineyard.

Dr. Charles Brenner, an expert on NAD metabolism and longevity supplements, joins the conversation to break down the science behind NAD and NMN. He explains how NAD coenzymes are crucial for energy metabolism and discusses their decline with age. The chat dives into the misconceptions surrounding these supplements and critiques popular longevity claims made by figures like Andrew Huberman and Peter Atiyah. Brenner emphasizes the importance of a healthy lifestyle over reliance on unproven treatments, making it clear that foundational health practices are essential.

Drs. Karl and Spencer chat with Dr. Fatima Cody Stanford all about obesity, genetics, and her appearance on 60 minutes.Does Dr. Sanford believe lifestyle doesn't matter for obesity?Find out by listening!Watch Dr. Stanford's 60 minute clip Join Dr. Spencer's Obesity Clinic

Drs. Karl and Spencer chat about the new Lancet Commission's report on Clinical Obesity along with the new study on high dosed Wegovy. Learn:How 7.2 mg of Wegovy (semaglutide) compares to 2.4 mgWhat the proposed definitions of clinical and preclinical obesity areClick here to join Dr. Spencer's new online clinic

This week, Alexandra Sowa, author of "The Ozempic Revolution," joins to discuss groundbreaking GLP-1 medications and their impact on weight management. She sheds light on why she wrote her book and shares crucial tips for those considering these treatments. The conversation also tackles the societal stigmas associated with obesity, revealing the psychological hurdles patients face. With laughter and insightful dialogue, they explore the evolution of obesity medicine and the importance of education in combating misinformation.

Delve into the intriguing concepts of microdosing GLP-1 receptor agonists and the latest results from a new weight loss drug. Discover the balance between ethical medication access and corporate practices in healthcare. Hear about the eccentric quest for longevity and the disparities in medication availability. Explore the implications of microdosing terzepatide on inflammation versus weight loss. Unpack the ethical concerns surrounding cosmetic weight loss medications and the importance of responsible pharmaceutical practices.